Skip to main content

Table 2 TA-TAVI infection vs no-infection demographic and operative variables

From: Surgical site infections following transcatheter apical aortic valve implantation: incidence and management

  No infection Infection P
  (n=149) (n=5)  
Age 78.7±7.9 75±6.3 0.3079
Men (%) 43.0 (64/149) 20 (1/5) 0.3067
Weight (kg) 67.1±14.9 78.2±10 0.0996
BMI 26.7±5.3 31.4±3.1 0.0504
HBP (%) 82.6 (123/149) 100 (5/5) 0.3056
DM (%) 34.2 (51/149) 20 (1/5) 0.5081
Cr.clearance (median) 39.7±16.5 (37.5) 44.1±19.9 (31.8) 0.5580
DLP (%) 89.9 (134/149) 100 (5/5) 0.4552
PVD (%) 45.6 (68/149) 40 (2/5) 0.8033
COPD (%) 26.2 (39/149) 40 (2/5) 0.4915
Stroke (%) 3.4 (5/149) 0 (0/5) 0.6771
GI comp (%) 6.7 (10/149) 20 (1/5) 0.2564
ARF (%) 18.1 (27/149) 20 (1/5) 0.9147
Septicaemia (%) 0 0 -
Bronchitis/Pneumonia (%) 21.5 (32/149) 40 (2/5) 0.3260
UTI (%) 18.1 (27/149) 20 (1/5) 0.9147
Death (%) 12.8 (19/149) 0 0.3938